Breast Cancer Home > Docefrez
Clinical EffectsOne study looked at using docetaxel (the active ingredient of Docefrez) to treat advanced or metastatic breast cancer (cancer that has spread to other areas of the body) in people who had not adequately responded to certain other types of chemotherapy. In this study, people were given either docetaxel or a combination of mitomycin (Mitozytrex®) and vinblastine (Velban®). Compared to the combination treatment, docetaxel increased survival from 8.7 months to 11.4 months. It also delayed the progression of the cancer by almost two months.
When and How to Receive ItSome general considerations to keep in mind during treatment with Docefrez include the following:
- This medication is given as a slow injection into a vein (an intravenous, or IV, infusion). It is usually given once every three weeks.
- The injections are normally administered by a healthcare provider in a healthcare setting, such as a hospital.
- It will take approximately one hour to receive your Docefrez dosage.
- For the medication to work properly, it must be used as prescribed.